|
HEATR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.75409950190442E-10 |
| Normal-vs-Stage2 |
3.033600E-02 |
| Normal-vs-Stage3 |
1.633050E-04 |
| Normal-vs-Stage4 |
3.958800E-04 |
| Stage1-vs-Stage2 |
7.271200E-01 |
| Stage1-vs-Stage3 |
4.980300E-02 |
| Stage1-vs-Stage4 |
1.556110E-02 |
| Stage2-vs-Stage3 |
4.267400E-01 |
| Stage2-vs-Stage4 |
1.835030E-01 |
| Stage3-vs-Stage4 |
4.320200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-15 |
| Normal-vs-AfricanAmerican |
1.66658999999347E-05 |
| Normal-vs-Asian |
1.282640E-01 |
| Caucasian-vs-AfricanAmerican |
4.448400E-01 |
| Caucasian-vs-Asian |
7.675600E-01 |
| AfricanAmerican-vs-Asian |
5.669400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33146835171283E-15 |
| Normal-vs-Female |
1.36299999953238E-07 |
| Male-vs-Female |
7.777800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.649220E-04 |
| Normal-vs-Extreme_Weight |
9.72250000508268E-08 |
| Normal-vs-Obese |
6.41249999988602E-07 |
| Normal-vs-Extreme_Obese |
4.984400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.432200E-01 |
| Normal_Weight-vs-Obese |
9.832800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.243000E-01 |
| Extreme_Weight-vs-Obese |
7.990000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.063400E-01 |
| Obese-vs-Extreme_Obese |
7.899600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.606000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.64290803184031E-12 |
| Normal-vs-Age(61-80Yrs) |
5.15570000025889E-08 |
| Normal-vs-Age(81-100Yrs) |
8.359900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.463600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.876180E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.457700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.289980E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.687200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.768000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
3.602300E-04 |
| Normal-VS-KIRP CIMP |
4.778100E-03 |
| Normal-VS-Unclassified PRCC |
2.194600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.266420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.590400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.171600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.491500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.050400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.870200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.462360E-03 |
| Normal-vs-N1 |
2.44399999999034E-05 |
| Normal-vs-N2 |
7.443700E-02 |
| N0-vs-N1 |
3.110000E-02 |
| N0-vs-N2 |
5.053000E-01 |
| N1-vs-N2 |
6.977200E-01 |
|
|
